Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-07-050079
Filing Date
2007-08-06
Accepted
2007-08-06 15:03:37
Documents
2
Period of Report
2007-07-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd167944.html 3  
1 FORM 3 rrd167944.xml 3 1498
2 POWER OF ATTORNEY rrd148596_167634.htm EX-24. 5192
  Complete submission text file 0001181431-07-050079.txt   8392
Mailing Address
Business Address 321 ARSENAL STREET WATERTOWN MA 02472 6176737800
OXIGENE INC (Issuer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O OXIGENE, INC. 230 THIRD AVENUE WALTHAM MA 02451
Business Address 781-547-5900
Walicke Patricia A. (Reporting) CIK: 0001408380 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-21990 | Film No.: 071027632